Medication info
Metformin Tablets 500mg (Metformin Hydrochloride)

Metformin Tablets 500mg (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
KMS Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201500640 · Approved 2015.02.06 · Insurance code 654701580

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on therapeutic effect and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, treatment with this drug must be initiated at a low dose: 500mg per dose, 2~3 times daily, with meals. The dose should be increased gradually by 500mg each week. When the dose is increased to 2000mg, it is usually divided into 2 doses daily, taken in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses daily with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, fasting blood glucose should be measured to assess the response to treatment with this drug and identify the minimum effective dose. Blood glycosylated hemoglobin levels should be measured at approximately 3-month intervals. The goal of treatment with this drug, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled with diet alone, short-term treatment with this drug may be sufficient to achieve an adequate effect. Patients with renal impairment: This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this drug must be discontinued immediately.
Child dose
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. The dose should be adjusted after measuring blood glucose levels one week later. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg, divided into 2~3 doses.

Ingredients

Manufacturer
KMS Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes with insufficient blood sugar control
View approved original text

This medication is used for the treatment of patients with Type 2 diabetes whose blood sugar control is not adequately managed with diet and exercise alone. It is particularly effective in overweight adult diabetic patients and can be used alone or in combination with other oral hypoglycemic agents or insulin. Additionally, it can also be used as monotherapy or in combination with insulin in children over the age of 10 and adolescents. This helps improve blood sugar control and maintain health.

How to take

Adult dose

The dose should be determined individually based on therapeutic effect and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, treatment with this drug must be initiated at a low dose: 500mg per dose, 2~3 times daily, with meals. The dose should be increased gradually by 500mg each week. When the dose is increased to 2000mg, it is usually divided into 2 doses daily, taken in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses daily with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, fasting blood glucose should be measured to assess the response to treatment with this drug and identify the minimum effective dose. Blood glycosylated hemoglobin levels should be measured at approximately 3-month intervals. The goal of treatment with this drug, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled with diet alone, short-term treatment with this drug may be sufficient to achieve an adequate effect. Patients with renal impairment: This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this drug must be discontinued immediately.

Child dose

Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. The dose should be adjusted after measuring blood glucose levels one week later. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg, divided into 2~3 doses.

Precautions

This medication may cause serious side effects such as severe lactic acidosis or hypoglycemia, so caution is needed. It should not be given to patients with moderate to severe renal impairment or those in acute conditions such as dehydration, severe infections, or acute myocardial infarction. In patients with acute and unstable heart failure, as well as before and after examinations using iodine contrast agents, this medication should be discontinued, and re-administration can only occur after kidney function has recovered to normal. It is not to be used in patients who have had allergic reactions to this medication or similar drugs, in type 1 diabetes patients, or in patients with a history of lactic acidosis or diabetic ketoacidosis. It should be used with caution in patients with severe infections, severe trauma, pre- and post-surgery, malnutrition, or liver or lung dysfunction, and administration should be temporarily stopped if necessary. This medication contains lactose, so it should not be given to patients with lactose intolerance or related genetic conditions. Caution is also required in cases of irregular meals, excessive exercise, or interactions with other medications, which may increase the risk of hypoglycemia or lactic acidosis. Lactic acidosis, though rare, can be fatal, so any symptoms such as malaise, muscle pain, shortness of breath, or abdominal pain should be immediately reported to medical personnel. Gastrointestinal disturbances are common at the initiation of treatment but are usually temporary and can be alleviated by taking the medication with meals or gradually increasing the dosage. Blood sugar control status should be regularly monitored, and kidney function and hematological values should be consistently monitored. Alcohol may increase the risk of side effects from this medication, so excessive drinking should be avoided. During pregnancy, it may affect the fetus, so it is essential to consult a physician if planning to become pregnant or during pregnancy, and it should not be administered if there is a risk of placental insufficiency or preeclampsia. During breastfeeding, as this medication may be secreted in breast milk, careful consideration should be given to whether to continue nursing or stop medication. In elderly patients, kidney function may decline, so dose adjustment and regular kidney function tests are necessary, and it is advisable not to administer the maximum dosage. In cases of overdose, the drug can be removed through hemodialysis, so if overdose occurs, medical attention should be sought immediately. This medication may interact with other hypoglycemic agents or multiple medications, so it is essential to inform medical personnel of any concurrent medications and closely monitor blood sugar and the patient's condition. Finally, this medication should be kept out of reach of children, and care should be taken not to transfer it to other containers as this may affect its quality.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • unpleasant taste
Show 8 more
  • metallic taste
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • abnormal liver function
  • severe delayed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, it is important to store it at room temperature, specifically between 1 degree and 30 degrees Celsius, to maintain its effectiveness.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.